Cancer Drug Cuts Inflammatory Response in Gout & Heart Disea

PLK1 inhibitors are cancer drugs that help to treat inflammatory diseases by suppressing 'NLRP3 inflammasome', responsible for triggering immune response.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , , University Of Cambridge , Plk1 Inhibitors , Cancer Drug , Lrp3 Inflammasome , Out , Heart Failure , Cardiomyopathy , Nd Atrial Fibrillation ,